No connection

Search Results

MCTA vs OFIX

MCTA
Charming Medical Limited
BEARISH
Price
$29.36
Market Cap
$504.3M
Sector
Healthcare
AI Confidence
95%
OFIX
Orthofix Medical Inc.
BEARISH
Price
$12.87
Market Cap
$516.7M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
MCTA
419.36
OFIX
--
Forward P/E
MCTA
--
OFIX
15.05
P/B Ratio
MCTA
9785.0
OFIX
1.14
P/S Ratio
MCTA
92.98
OFIX
0.63
EV/EBITDA
MCTA
388.4
OFIX
-103.87

Profitability

Gross Margin
MCTA
96.02%
OFIX
68.83%
Operating Margin
MCTA
-0.94%
OFIX
-1.27%
Profit Margin
MCTA
12.12%
OFIX
-11.21%
ROE
MCTA
--
OFIX
-19.34%
ROA
MCTA
10.63%
OFIX
-4.91%

Growth

Revenue Growth
MCTA
-27.0%
OFIX
2.0%
Earnings Growth
MCTA
--
OFIX
--

Financial Health

Debt/Equity
MCTA
1.6
OFIX
0.45
Current Ratio
MCTA
0.59
OFIX
2.44
Quick Ratio
MCTA
0.57
OFIX
1.28

Dividends

Dividend Yield
MCTA
--
OFIX
--
Payout Ratio
MCTA
0.0%
OFIX
0.0%

AI Verdict

MCTA BEARISH

MCTA exhibits a severe disconnect between its market price and fundamental value, with a Piotroski F-Score of 6/9 indicating stable internal health but failing to justify a valuation that dwarfs its Graham Number ($0.07) and Intrinsic Value ($0.49). The company is trading at an astronomical Price-to-Book ratio of 9785.00 and a P/E of 419.36 despite a significant revenue contraction of 27% YoY. While gross margins are exceptionally high, negative operating margins and a current ratio of 0.59 signal poor operational efficiency and liquidity risks. The technical trend is heavily bearish, suggesting a speculative bubble that is currently deflating.

Strengths
Stable Piotroski F-Score (6/9)
Exceptionally high gross margins (96.02%)
Positive net profit margin (12.12%)
Risks
Extreme overvaluation (Price vs. Intrinsic Value)
Significant revenue decline (-27% YoY)
Severe liquidity risk (Current Ratio 0.59)
OFIX BEARISH

OFIX exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor operational health. While the company maintains a strong gross margin and a healthy current ratio, these are offset by negative profit margins and stagnant revenue growth of only 2%. The long-term price trajectory is devastating, with a 5-year decline of 70.9%, and insider sentiment is decidedly bearish with consistent selling. Despite optimistic analyst price targets, the high PEG ratio of 8.48 suggests the stock is significantly overvalued relative to its actual growth profile.

Strengths
Strong gross margin of 68.83%
Healthy liquidity with a current ratio of 2.44
Manageable leverage with a Debt/Equity ratio of 0.45
Risks
Critically low Piotroski F-Score (2/9) signaling financial deterioration
Stagnant revenue growth (2.00% YoY) failing to drive expansion
Negative profitability (Profit Margin -11.21%, ROE -19.34%)

Compare Another Pair

MCTA vs OFIX: Head-to-Head Comparison

This page compares Charming Medical Limited (MCTA) and Orthofix Medical Inc. (OFIX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile